Tamarind Health’s acquisition of TalkMed cleared by Singapore
MLex Summary: Singapore’s Competition and Consumer Commission, or CCCS, has approved Tamarind Health’s proposed acquisition of TalkMed Group, concluding that the deal is unlikely to substantially lessen competition in the private...To view the full article, register now.
Already a subscriber? Click here to view full article